Schedule 13G ownership disclosure
HERON THERAPEUTICS, INC.
Common Stock, par value $0.01 per share · CUSIP: 427746102
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Clearline Capital LP
Shares: 9,712,527.00 · Class: 5.3%
- Clearline Capital LLC
Shares: 9,712,527.00 · Class: 5.3%
- Marc Majzner
Shares: 9,712,527.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001600136-25-000011
- Form type
- SCHEDULE 13G
- Filer
- Clearline Capital LP
- CIK
- CIK 1600136
- Filed
- Nov 26, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership